Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Extension Trial to Determine Tolerability and Efficacy of Long-term Oral SPM 927 as Adjunctive Therapy in Patients With Partial Seizures

NCT00552305 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00552305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00552305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Extension Trial to Determine Tolerability and Efficacy of Long-term Oral SPM 927 as Adjunctive Therapy in Patients With Partial Seizures
Lead sponsor
UCB Pharma
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2001
Completion date
February 28, 2010
Enrollment
370 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

partial epilepsies